+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Substance P Promotes the Progression of Endometrial Adenocarcinoma



Substance P Promotes the Progression of Endometrial Adenocarcinoma



International Journal of Gynecological Cancer 26(5): 845-850



It has been demonstrated that substance P (SP) promotes while neurokinin-1 receptor (NK-1R) antagonist inhibits the proliferation of several human cancer cells. Currently, it is still unknown whether such actions exist in human endometrial carcinoma. This study aimed to explore the role of SP/NK-1R signaling in the progression of endometrial adenocarcinoma. The expression levels of SP and NK-1R in endometrial adenocarcinoma tissues and Ishikawa cell line were detected by real-time quantitative PCR and Western blot analysis. The effects of SP on Ishikawa cells proliferation and invasion were analyzed using MTT assay and transwell matrigel invasion assay, respectively. The expression levels of matrix metalloproteinase 9 (MMP-9) and vascular endothelial growth factor C (VEGF-C) in Ishikawa cells after administration of SP were detected by real-time quantitative RCR and Western blot analysis. The expression levels of SP and NK-1R were significantly higher in endometrial adenocarcinoma tissues and Ishikawa cells than in normal endometrium. Substance P significantly enhanced the proliferation and invasion of Ishikawa cells. In addition, SP induced the expression of MMP-9 and VEGF-C in Ishikawa cells, whereas NK-1R antagonist inhibited these effects. Substance P plays an important role in the development of endometrial carcinoma by inducing the expression of MMP-9 and VEGF-C and promoting cancer cell proliferation and metastasis, which can be blocked by NK-1R antagonist.

(PDF emailed within 0-6 h: $19.90)

Accession: 058926829

Download citation: RISBibTeXText

PMID: 27051050

DOI: 10.1097/IGC.0000000000000683


Related references

Overexpression of p21-activated kinase 1 promotes endometrial cancer progression. Oncology Reports 29(4): 1547-1555, 2013

Role of tumor-associated glycoprotein-72 in the progression of endometrial adenocarcinoma: a proposed study. Medical Hypotheses 84(5): 413-416, 2015

SCF, regulated by HIF-1α, promotes pancreatic ductal adenocarcinoma cell progression. Plos One 10(3): E0121338, 2016

Cathepsin B promotes the progression of pancreatic ductal adenocarcinoma in mice. Gut 61(6): 877-884, 2012

Up-regulation of microRNA-145 promotes differentiation by repressing OCT4 in human endometrial adenocarcinoma cells. Cancer 117(17): 3989-3998, 2011

Loss of CD73-mediated actin polymerization promotes endometrial tumor progression. Journal of Clinical Investigation 126(1): 220-238, 2016

G protein-coupled estrogen receptor (GPER) expression in endometrial adenocarcinoma and effect of agonist G-1 on growth of endometrial adenocarcinoma cell lines. Steroids 78(11): 1087-1091, 2014

Oestrogen receptor-mediated expression of Olfactomedin 4 regulates the progression of endometrial adenocarcinoma. Journal of Cellular and Molecular Medicine 18(5): 863-874, 2015

A close correlation between c-erbB-2 gene amplification and local progression in endometrial adenocarcinoma. European Journal of Gynaecological Oncology 19(1): 90-92, 1998

Morphometric analysis of endometrial adenocarcinoma: 1. Does architectural dedifferentiation accompany deep invasion by endometrial adenocarcinoma?. International Journal of Gynecological Pathology 6(1): 12-19, 1987

LTPB2 acts as a prognostic factor and promotes progression of cervical adenocarcinoma. American Journal of Translational Research 7(6): 1095-1105, 2015

LKB1 loss promotes endometrial cancer progression via CCL2-dependent macrophage recruitment. Journal of Clinical Investigation 125(11): 4063-4076, 2016

Chemokine (C-C) motif ligand 20 is regulated by PGF(2α)-F-prostanoid receptor signalling in endometrial adenocarcinoma and promotes cell proliferation. Molecular and Cellular Endocrinology 331(1): 129-135, 2011

Overexpression of long noncoding RNA, NEAT1 promotes cell proliferation, invasion and migration in endometrial endometrioid adenocarcinoma. Biomedicine and PharmacoTherapy 84: 244-251, 2016

Overexpression of Long Non-Coding RNA ZXF2 Promotes Lung Adenocarcinoma Progression Through c-Myc Pathway. Cellular Physiology and Biochemistry 35(6): 2360-2370, 2016